Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
15 papers
Recent·Most cited
T. Tamura, K. Mizuma, H. Nasser, S. Deguchi, M. Padilla-Blanco, K. Uriu, J. E. M. Tolentino, S. Tsujino, R. Suzuki, I. Kojima, N. Nao, R. Shimizu, M. Jonathan, Y. Kosugi, Z. Guo, , K. Sato
This study investigates the virological characteristics of the SARS-CoV-2 BA.2.86 variant, finding it has higher reproduction number than EG.5.1 but lower pathogenicity and replication capacity compared to BA.2.
bioRxiv · Nov 2, 2023Microbiology
S. Tsujino, S. Deguchi, T. Nomai, M. Padilla-Blanco, A. Plianchaisuk, L. Wang, M. M. Begum, K. Uriu, K. Mizuma, N. Nao, I. Kojima, T. Tsubo, J. Li, Y. Matsumura, M. Nagao, , Za
The paper investigates the virological features of the SARS-CoV-2 EG.5.1 variant, finding its fitness and antiviral sensitivity comparable to XBB.1.5, with structural differences in spike proteins.
bioRxiv · Oct 19, 2023Microbiology
R. Hamashima, M. Tashiro, Y. Nakano, H. Namie, Y. Ito, T. Hirayama, K. Takeda, N. Iwanaga, K. Nishi, H. Liu, T. Takazono, T. Tanaka, A. Watanabe, Y. Komohara, A. Furumoto, , K. Izumikawa
This paper develops a novel mouse model of aspergilloma to study host-fungal interactions, revealing Th1/Th17 responses and angiogenesis induced by dead fungal hyphae.
bioRxiv · Oct 6, 2023 · PreprintMicrobiology
T. Tamura, T. Irie, S. Deguchi, H. Yajima, M. Tsuda, H. Nasser, K. Mizuma, A. Plianchaisuk, S. Suzuki, K. Uriu, M. M. Begum, R. Shimizu, M. Jonathan, R. Suzuki, T. Kondo, , T. Fukuhara
The paper analyzes the virological characteristics of the SARS-CoV-2 XBB.1.5 variant, showing reduced pathogenicity and impaired MHC expression due to mutations in ORF8 and S.
bioRxiv · Aug 16, 2023 · PreprintMicrobiology
T. Tamura, J. Ito, K. Uriu, J. Zahradnik, I. Kida, H. Nasser, M. Shofa, Y. Oda, S. Lytras, N. Nao, Y. Itakura, S. Deguchi, R. Suzuki, L. Wang, M. M. Begum, , K. Sato
This study identifies XBB as a SARS-CoV-2 variant resulting from recombination of BA.2 subvariants, showing increased resistance to neutralizing antibodies and enhanced fusogenicity compared to BA.2.75.
bioRxiv · Dec 27, 2022 · PreprintMicrobiology
J. Ito, R. Suzuki, K. Uriu, Y. Itakura, J. Zahradnik, S. Deguchi, L. Wang, S. Lytras, T. Tamura, I. Kida, H. Nasser, M. Shofa, M. M. Begum, M. Tsuda, Y. Oda, , K. Sato
The paper investigates convergent evolution in SARS-CoV-2 Omicron subvariants, identifying five critical spike protein substitutions in BQ.1.1 that enhance viral fitness and antibody resistance.
bioRxiv · Dec 5, 2022Microbiology
T. Tamura, D. Yamasoba, Y. Oda, J. Ito, T. Kamasaki, N. Nao, R. Hashimoto, Y. Fujioka, R. Suzuki, L. Wang, H. Ito, I. Kimura, I. Yokota, M. Kishimoto, M. Tsuda, , T. Fukuhara
This study compares the pathogenicity of SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.5, finding BA.5 is more fusogenic and induces stronger inflammation than earlier variants.
bioRxiv · Aug 5, 2022Microbiology
A. Saito, T. Tamura, J. Zahradnik, S. Deguchi, K. Tabata, I. Kimura, J. Ito, H. Nasser, M. Toyoda, K. Nagata, K. Uriu, Y. Kosugi, S. Fujita, D. Yamasoba, M. Shofa, , Kei Sato
This study investigates the virological characteristics of SARS-CoV-2 Omicron BA.2.75, finding it has higher transmissibility and pathogenicity compared to BA.2 and BA.5, but similar sensitivity to antiviral drugs.
bioRxiv · Jul 14, 2022Microbiology
T. Tanaka, A. Saito, T. Suzuki, Y. Miyamoto, K. Takayama, T. Okamoto, K. Moriishi
This study develops a stable SARS-CoV-2 replicon system for high-throughput antiviral screening under BSL2 conditions, demonstrating its utility with remdesivir and interferon-β.
bioRxiv · Dec 23, 2021Microbiology
A. Tunon-Molina, A. Cano-Vicent, M. Marti, Y. Muramoto, T. Noda, K. Takayama, A. Serrano-Aroca
This paper develops non-woven fabrics coated with cranberry extracts that inactivate SARS-CoV-2, phage phi 6, and multidrug-resistant bacteria, validated using a C. elegans model.
bioRxiv · Aug 14, 2021Bioengineering
A. Cano-Vicent, A. Tunon-Molina, M. Marti, Y. Muramoto, T. Noda, K. Takayama, A. Serrano-Aroca
This paper describes an antiviral face mask made with solidified hand soap-coated fabric that inactivates enveloped viruses like SARS-CoV-2 within one minute and is non-toxic to human cells.
bioRxiv · Aug 13, 2021Bioengineering
E. Sano, A. Sakamoto, N. Mimura, A. Hirabayashi, Y. Muramoto, T. Noda, T. Yamamoto, K. Takayama
This study uses ACE2-expressing human iPS cells to model SARS-CoV-2 infection and shows sex-based differences in viral production.
bioRxiv · Feb 22, 2021Cell Biology
M. Marti, A. Tunon-Molina, F. L. Aachmann, Y. Muramoto, T. Noda, K. Takayama, A. Serrano-Aroca
This paper develops a face mask filter with a biofunctional coating that inactivates SARS-CoV-2 and methicillin-resistant bacteria within one minute of contact.
bioRxiv · Nov 24, 2020Bioengineering
T. Suzuki, Y. Ito, Y. Sakai, A. Saito, D. Okuzaki, D. Motooka, S. Minami, T. Kobayashi, T. Yamamoto, T. Okamoto, K. Takayama
This paper generates human bronchial organoids that support SARS-CoV-2 infection and drug testing, showing reduced viral load with TMPRSS2 inhibition.
bioRxiv · May 25, 2020Cell Biology
G. Vares, V. Jallet, Y. Matsumoto, C. Rentier, K. Takayama, T. Sasaki, Y. Hayashi, H. Kumada, H. Sugawara
This study develops B-MSNs for BNCT to treat chondrosarcomas, showing DNA damage and cell death in radio-resistant CSCs.
bioRxiv · Nov 18, 2019Cancer Biology